Advertisement Roxane Laboratories launches generic transplant drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roxane Laboratories launches generic transplant drug

US-based pharmaceutical company Roxane Laboratories has launched its generic for mycophenolate mofetil 250mg capsules and 500mg tablets by the FDA.

These products are available in 250mg capsules bottles of 100 and 500 and 500mg tablets bottles of 100 and 500. They are available for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories’s mycophenolate mofetil 250mg capsules and 500mg tablets are AB rated to CellCept capsules and tablets.